Aethlon Medical, Inc. (AEMD) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Aethlon Medical, Inc., a Nevada corporation, with a report date of August 28, 2026. The filing addresses a corporate event under Item 8.01 (Other Events) regarding the company's capital structure.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on share count updates resulting from warrant exercises.
Material Changes
- Warrant Exercises: The company reported recent exercises of certain pre-funded warrants.
- Share Count Update: As of the close of business on August 28, 2026, the company has 1,604,095 shares of common stock outstanding.
- Warrant Status: All previously outstanding pre-funded warrants have been fully exercised.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on operations, specific risks, contingencies, or unusual items beyond the warrant exercise event.
Investor Verification Checklist
- Verify the total number of shares outstanding (1,604,095) in subsequent filings or stock exchange data.
- Confirm the cash proceeds, if any, generated from the exercise of the pre-funded warrants.
- Review the company's most recent 10-K or 10-Q for current liquidity and operational status, as this 8-K contains no financial performance data.